| Literature DB >> 34319537 |
Jaffar Hussain Bukhari1,2, Abdul Samad Khan3, Kashif Ijaz4, Shahreen Zahid1,5, Aqif Anwar Chaudhry6, Muhammad Kaleem1.
Abstract
A novel way was adopted to graft zinc oxide (ZnO) with urethane-modified dimethacrylate (UDMA) in order to utilize them as reinforcing agents in resin-based dental composites. Experimental novel composites were synthesized having UDMA-grafted and nongrafted ZnO, at a concentration of 0 wt.%, 5 wt.%, and 10 wt.%. The same concentrations of ZnO were also incorporated in Filtek Z250 XT (3 M ESPE, USA). The antibacterial behavior was evaluated against Streptococcus mutans by direct-contact test at one, three, and seven days of incubation. The compressive strength and Vickers microhardness were tested as per ISO 9917 and ISO/CD6507-1, respectively. For abrasive wear resistance, mass loss and roughness average after tooth-brushing cycles of 24,000 at custom-made tooth-brushing simulator were evaluated using noncontact profilometer. Data analysis was carried out using post hoc Tucky's test and nonparametric Kruskal-Wallis test. Direct contact test revealed that the antibacterial potential of novel and commercial composites was increased with an increase in the concentration of grafted ZnO as compared with nongrafted, whereby the potential was the highest at day seven. There was a significant decrease in compressive strength and Vickers hardness of commercial composites on addition of grafted ZnO while there was no significant difference in the strength of experimental novel composite. The abrasive wear of commercial and experimental composites was within clinical limits. Low-temperature flow-synthesis method was successfully employed to synthesize grafted and nongrafted ZnO. The UDMA-grafted ZnO can be incorporated into dental composites without decreasing their strength and these composites can be used to combat secondary caries.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34319537 PMCID: PMC8318967 DOI: 10.1007/s10856-021-06560-4
Source DB: PubMed Journal: J Mater Sci Mater Med ISSN: 0957-4530 Impact factor: 3.896
Composition and groups of composite used in the current study
| Commercial composite (Filtek Z250 XT) | |||
|---|---|---|---|
| Group name | Organic components | Inorganic fillers | |
| Reinforcing Agents | Active ingredient | ||
| CG5 | Silanized Zirconia,/ Silica 82% (w/w) | UDMA grafted ZnO, 5 wt.% | |
| CG10 | UDMA grafted ZnO, 10 wt.% | ||
| CNG5 | Non-grafted ZnO, 5 wt.% | ||
| CNG10 | Non-grafted ZnO, 10 wt.% | ||
| C | as received from the manufacturer | ||
| EG5 | Silica 40% (w/w) | UDMA grafted ZnO, 5 wt.% | |
| EG10 | UDMA grafted ZnO, 10 wt.% | ||
| ENG5 | Non-grafted ZnO, 5 wt.% | ||
| ENG10 | Non-grafted ZnO, 10 wt.% | ||
| E | 0 wt.% | ||
Fig. 1a FTIR spectra of UDMA-grafted and nongrafted ZnO particles b TGA graph of pure and UDMA-grafted ZnO showing the mass loss after heating at 1000 °C
Fig. 2XRD pattern showing peaks of (a) pure ZnO and (b) UDMA-grafted ZnO
Fig. 3CFU/mL of commercial composite groups and experimental novel composite groups at days one, three, and seven
Fig. 4Mean CS and Vickers hardness values (a and c) of commercial composites and (b and d) experimental novel composites, respectively
Fig. 5Mean mass loss and ΔRa values (a and c) Commercial composite groups (b and d) Experimental composite groups, respectively
Pre and post-test roughness average of commercial and experimental novel composite groups
| Group name | Roughness average (µm) | |
|---|---|---|
| Rai | Raf | |
| CG5 | 24.19 ± 16.37 | 10.73 ± 7.47 |
| CG10 | 20.35 ± 13.43 | 11.51 ± 4.51 |
| CNG5 | 8.49 ± 5.56 | 9.81 ± 5.74 |
| CNG10 | 15.67 ± 13.59 | 11.63 ± 5.57 |
| C | 21.11 ± 16.37 | 8.29 ± 5.34 |
| EG5 | 34.48 ± 11.87 | 9.53 ± 4.57 |
| EG10 | 9.49 ± 3.77 | 10.51 ± 5.20 |
| ENG5 | 12.20 ± 4.66 | 14.55 ± 7.51 |
| ENG10 | 5.86 ± 3.27 | 11.33 ± 5.55 |
| E | 5.63 ± 2.56 | 6.83 ± 5.29 |